PHARMA REGULATORY SERVICES LIMITEDActive

Company number 06384162Private limited companyIncorporated 2007

Key figures

£540,596+2.6%
Net assets 2024/25
+1.2%
Average annual growth 2020/21–2024/25
0200 k400 k600 k2020/212021/222022/232023/242024/25

Like most small UK companies, PHARMA REGULATORY SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand200,968162,968160,363333,49362,416
Total assets574,438535,407———
Total liabilities51,6608,9431,1965703,296
Net assets / total equity516,404520,090524,746526,686540,596
Average number of employees22211

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMA REGULATORY SERVICES LIMITED

Company

PHARMA REGULATORY SERVICES LIMITED is a private limited company registered with Companies House under company number 06384162. It was incorporated on 27 Sep 2007. Its status is active. The registered office is in Middlesex (UB10). Its nature of business (SIC 2007) is buying and selling of own real estate (68100), other letting and operating of own or leased real estate (68209), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £540,596, up 2.6% on the previous year. Cash at bank and in hand was £62,416. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 2 Sep 2027.